Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis

Lancet

Volumn 358, Issue 9295, 2001, Pages 1780-1781

  De Soyza, Anthony ^a   McDowell, Andrew ^b   Archer, Lynda ^a   Dark, John H ^a   Elborn, Stuart J ^b   Mahenthiralingam, Eshwar ^c   Gould, Kate ^a   Corris, Paul A ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENOTYPE; HEALTH STATUS; HUMAN; INFECTION RATE; LUNG INFECTION; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035944832     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06808-8     Document Type: Article

References (5)

1. Infection with Burkholderia cepacia in cystic fibrosis: Outcome following lung transplantation
2. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III
3. Survival following lung transplantation of cystic fibrosis patients colonized with Burkholderia cepacia
4. Lung transplantation in cystic fibrosis: Consensus conference statement
5. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia